CAPR vs CLOV
Capricor Therapeutics Inc (CAPR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CAPR revenue for 2024-12-31 was $22.3M. Net income was -$40.5M. Revenue was down 11.5% from 2023-12-31 to 2024-12-31. CAPR currently screens at market cap $1.62B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CAPR currently screens at market cap $1.62B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CAPR and CLOV stock pages for the full models.
Not investment advice.